Brief: PolyPid Announces Top-Line Results Of Phase 3 Shield I Trial Of D-Plex₁₀₀ For Prevention Of Surgical Site Infections In Abdominal Surgery

Polypid

02/09/2022 14:36

Sept 2 (Reuters) - PolyPid Ltd  PYPD.O :
    * POLYPID ANNOUNCES TOP-LINE RESULTS OF PHASE 3 SHIELD I
TRIAL OF
D-PLEX₁₀₀ FOR THE PREVENTION OF SURGICAL SITE INFECTIONS IN
ABDOMINAL SURGERY
    * POLYPID LTD - SHIELD I STUDY DID NOT ACHIEVE ITS PRIMARY
ENDPOINT OF REDUCTION IN SURGICAL SITE INFECTIONS AND MORTALITY
    * POLYPID LTD - NO SAFETY CONCERNS RAISED BY INDEPENDENT
DATA
SAFETY MONITORING BOARD IN SHIELD I
    * POLYPID LTD - WITHIN FIRST 30 DAYS POST-SURGERY, THERE
WERE 15
DEATHS IN SOC TREATMENT ARM, AS COMPARED TO 11 IN D-PLEX100
TREATMENT ARM

Source text for Eikon:  ID:nGNX2KsHvP 
Further company coverage:  PYPD.O 

 ((Reuters.Briefs@thomsonreuters.com;))